Anthony Kirck
Comptroller/Controller/Auditor bei OPTINOSE, INC.
Vermögen: 130 309 $ am 30.04.2024
Profil
Anthony Kirck is currently the Chief Accounting Officer, VP & Controller at OptiNose, Inc. Prior to his current position, he worked as the Executive Director-Financial Planning & Analysis at Strongbridge Biopharma Plc from 2017 to 2020.
He also served as the Controller at Verrica Pharmaceuticals, Inc. from 2020 to 2021.
Mr. Kirck completed his undergraduate degree at Albright College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
OPTINOSE, INC.
0,13% | 18.03.2024 | 143 988 ( 0,13% ) | 130 309 $ | 30.04.2024 |
Aktive Positionen von Anthony Kirck
| Unternehmen | Position | Beginn |
|---|---|---|
| OPTINOSE, INC. | Comptroller/Controller/Auditor | 01.11.2021 |
Ehemalige bekannte Positionen von Anthony Kirck
| Unternehmen | Position | Ende |
|---|---|---|
| VERRICA PHARMACEUTICALS INC. | Comptroller/Controller/Auditor | 01.11.2021 |
| STRONGBRIDGE BIOPHARMA | Corporate Officer/Principal | 01.02.2020 |
Ausbildung von Anthony Kirck
| Albright College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| OPTINOSE, INC. | Health Technology |
| VERRICA PHARMACEUTICALS INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Strongbridge Biopharma Plc
 Strongbridge Biopharma Plc Pharmaceuticals: MajorHealth Technology Strongbridge Biopharma Plc operates as a commercial-stage biopharmaceutical company, which focuses on the development and commercialization of therapies for rare diseases. Its pipeline is comprised of Keveyis, Macrilen, Recorlev, and Veldoreotide. The company was founded in 1996 and is headquartered in Trevose, PA. | Health Technology |
